01 194ASTRAZENECA AB
01 110973836*PED
02 111826376*PED
03 111903955*PED
04 156515117
05 136515117*PED
06 27456254
07 27456254*PED
08 27851502
09 27851502*PED
10 137919598
11 137919598*PED
12 48221786
13 48221786*PED
14 68329648
15 28329648*PED
16 88361972
17 48361972*PED
18 28431685
19 28431685*PED
20 28461105
21 28461105*PED
22 158501698
23 138501698*PED
24 68628799
25 78685934
26 78685934*PED
27 88716251
28 88716251*PED
29 28721615
30 99616028
31 110973836
32 111826376
33 111903955
34 28721615*PED
35 28906851
36 28906851*PED
37 99616028*PED
01 28Y
02 166Blank
01 61Y
02 133Blank
01 42025-04-13
02 22025-06-30
03 62025-07-13
04 152025-10-04
05 42025-10-13
06 22025-12-30
07 132026-04-04
08 82026-08-18
09 42027-02-18
10 152027-06-20
11 132027-12-20
12 202028-03-21
13 22028-08-19
14 162028-09-21
15 22029-02-19
16 132029-12-16
17 22030-01-18
18 72030-05-26
19 132030-06-16
20 22030-07-18
21 92030-11-12
22 72030-11-26
23 92031-05-12
24 12039-07-18
25 12040-01-18
26 22040-03-09
27 22040-09-09
Patent Expiration Date : 2030-05-26
US Patent Number : 8685934
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-1522
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2030-05-26
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2025-10-04
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 6515117
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2025-10-04
Patent Expiration Date : 2027-06-20
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8501698
Drug Substance Claim :
Drug Product Claim : Y
Application Number : 205649
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-06-20
Patent Expiration Date : 2030-05-26
DAPAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8685934
Drug Substance Claim :
Drug Product Claim :
Application Number : 205649
Patent Use Code : U-1522
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2030-05-26
Patent Expiration Date : 2026-08-18
US Patent Number : 8906851
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-2139
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-18
Patent Expiration Date : 2026-08-18
US Patent Number : 8329648
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-2213
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-18
Patent Expiration Date : 2026-08-18
US Patent Number : 8329648
Drug Substance Claim :
Drug Product Claim :
Application Number : 202293
Patent Use Code : U-2139
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2026-08-18
